Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Changes in serum leptin do not correlate to total fat mass in patients with thyrotoxicosis

    Zimmermann-Belsing, T., Dreyer, M., Holst, Jens Juul & Feldt-Rasmussen, U., 1998, In: J. Endocrinol.. 49, p. 589-595

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs

    Wojdemann, M., Wettergren, A., Hartmann, B. & Holst, Jens Juul, 1998, In: Scandinavian Journal of Gastroenterology. 33, p. 828-832

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Inhibition of human gastric lipase secretion by glucagon-like peptide-1

    Wojdemann, M., Wettergren, A., Sternby, B., Holst, Jens Juul, Larsen, S., Rehfeld, J. F. & Olsen, O., 1998, In: Dig. Dis. Sci.. 43, p. 799-805

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients

    Willms, B., Idowu, K., Holst, Jens Juul, Creutzfeldt, W. & Nauck, M. A., 1998, In: Exp. Clin. Endocrinol. Diabetes. 106, p. 103-107

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide.

    Wettergren, A., Wojdemann, M. & Holst, Jens Juul, 1998, In: Peptides. 19, p. 877-882

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans

    Wettergren, A., Pridal, L., Wöjdemann, M. & Holst, Jens Juul, 1998, In: Regul. Pept.. 77, p. 83-88

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow

    Wettergren, A., Wojdemann, M. & Holst, Jens Juul, 1998, In: Am. J. Physiol.. 275, p. G984-G992

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms

    Tolessa, T., Gutniak, M. K., Holst, Jens Juul, Efendic, S. & Hellstrom, P. M., 1998, In: Dig. Dis. Sci.. 43, p. 2284-2290

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

    Tolessa, T., Gutniak, M. K., Holst, Jens Juul, Efendic, S. & Hellstrom, P. M., 1998, In: J. Clin. Invest.. 102, p. 764-774

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia

    Toft-Nielsen, M., Madsbad, Sten & Holst, Jens Juul, 1998, In: Diabetologia. 41, 10, p. 1180-1186 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207